CN113881435B - Rare earth doped silver selenide quantum dot and synthesis method thereof - Google Patents
Rare earth doped silver selenide quantum dot and synthesis method thereof Download PDFInfo
- Publication number
- CN113881435B CN113881435B CN202111188492.8A CN202111188492A CN113881435B CN 113881435 B CN113881435 B CN 113881435B CN 202111188492 A CN202111188492 A CN 202111188492A CN 113881435 B CN113881435 B CN 113881435B
- Authority
- CN
- China
- Prior art keywords
- rare earth
- solution
- quantum dots
- synthesis method
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052761 rare earth metal Inorganic materials 0.000 title claims abstract description 22
- 238000001308 synthesis method Methods 0.000 title claims abstract description 12
- 150000002910 rare earth metals Chemical class 0.000 title claims abstract description 7
- 239000002096 quantum dot Substances 0.000 title abstract description 34
- KDSXXMBJKHQCAA-UHFFFAOYSA-N disilver;selenium(2-) Chemical compound [Se-2].[Ag+].[Ag+] KDSXXMBJKHQCAA-UHFFFAOYSA-N 0.000 title abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 33
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims abstract description 20
- -1 rare earth metal salt Chemical class 0.000 claims abstract description 17
- KRRRBSZQCHDZMP-UHFFFAOYSA-N selanylidenesilver Chemical class [Ag]=[Se] KRRRBSZQCHDZMP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 8
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims abstract description 8
- 229940071536 silver acetate Drugs 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 239000003446 ligand Substances 0.000 claims abstract description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002243 precursor Substances 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 239000011261 inert gas Substances 0.000 claims abstract description 3
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 9
- DVWQNBIUTWDZMW-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalen-2-ol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=CC=CC2=C1 DVWQNBIUTWDZMW-UHFFFAOYSA-N 0.000 claims description 6
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 claims description 5
- HDGGAKOVUDZYES-UHFFFAOYSA-K erbium(iii) chloride Chemical compound Cl[Er](Cl)Cl HDGGAKOVUDZYES-UHFFFAOYSA-K 0.000 claims description 5
- ATINCSYRHURBSP-UHFFFAOYSA-K neodymium(iii) chloride Chemical compound Cl[Nd](Cl)Cl ATINCSYRHURBSP-UHFFFAOYSA-K 0.000 claims description 5
- CKLHRQNQYIJFFX-UHFFFAOYSA-K ytterbium(III) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Yb+3] CKLHRQNQYIJFFX-UHFFFAOYSA-K 0.000 claims description 5
- 150000003573 thiols Chemical class 0.000 claims description 4
- ZAPYLSLVQJQGEY-UHFFFAOYSA-N 1-naphthalen-1-ylnaphthalen-2-amine Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3N)=CC=CC2=C1 ZAPYLSLVQJQGEY-UHFFFAOYSA-N 0.000 claims description 3
- RUJHATQMIMUYKD-UHFFFAOYSA-N 2-naphthalen-1-ylethanamine Chemical compound C1=CC=C2C(CCN)=CC=CC2=C1 RUJHATQMIMUYKD-UHFFFAOYSA-N 0.000 claims description 3
- MNZAKDODWSQONA-UHFFFAOYSA-N 1-dibutylphosphorylbutane Chemical compound CCCCP(=O)(CCCC)CCCC MNZAKDODWSQONA-UHFFFAOYSA-N 0.000 claims description 2
- YAJYJWXEWKRTPO-UHFFFAOYSA-N 2,3,3,4,4,5-hexamethylhexane-2-thiol Chemical compound CC(C)C(C)(C)C(C)(C)C(C)(C)S YAJYJWXEWKRTPO-UHFFFAOYSA-N 0.000 claims description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 2
- RMZAYIKUYWXQPB-UHFFFAOYSA-N trioctylphosphane Chemical compound CCCCCCCCP(CCCCCCCC)CCCCCCCC RMZAYIKUYWXQPB-UHFFFAOYSA-N 0.000 claims description 2
- ZMBHCYHQLYEYDV-UHFFFAOYSA-N trioctylphosphine oxide Chemical compound CCCCCCCCP(=O)(CCCCCCCC)CCCCCCCC ZMBHCYHQLYEYDV-UHFFFAOYSA-N 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 4
- 238000002983 circular dichroism Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000005540 biological transmission Effects 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 238000000862 absorption spectrum Methods 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- RWLIDRPIMIEHGZ-UHFFFAOYSA-N octadecane-1,18-dithiol Chemical compound SCCCCCCCCCCCCCCCCCCS RWLIDRPIMIEHGZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000013307 optical fiber Substances 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 17
- 239000011669 selenium Substances 0.000 description 10
- 229960001701 chloroform Drugs 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- GOBNDSNLXZYUHQ-UHFFFAOYSA-N selenium;tributylphosphane Chemical compound [Se].CCCCP(CCCC)CCCC GOBNDSNLXZYUHQ-UHFFFAOYSA-N 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229910000661 Mercury cadmium telluride Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- GNWCVDGUVZRYLC-UHFFFAOYSA-N [Se].[Ag].[Ag] Chemical compound [Se].[Ag].[Ag] GNWCVDGUVZRYLC-UHFFFAOYSA-N 0.000 description 1
- DLIJPAHLBJIQHE-UHFFFAOYSA-N butylphosphane Chemical compound CCCCP DLIJPAHLBJIQHE-UHFFFAOYSA-N 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/88—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing selenium, tellurium or unspecified chalcogen elements
- C09K11/881—Chalcogenides
- C09K11/886—Chalcogenides with rare earth metals
Landscapes
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
技术领域technical field
本发明属于材料化学技术领域,尤其是涉及一种手性近红外二区荧光硒化银量子点的合成方法。The invention belongs to the technical field of material chemistry, in particular to a method for synthesizing chiral near-infrared second-region fluorescent silver selenide quantum dots.
背景技术Background technique
由于长波长的光在活体组织中的散射低、穿透深度好,近红外二区(1000-1700nm)成像在活体成像上相对于传统的近红外一区(650-950nm)成像具有明显的优势,使得近红外量子点因其能克服可见光量子点进行深层组织成像时易受干扰的缺陷等,能够获得更高分辨的图像,因而成为了目前光学成像领域的热点。并且,随着生物成像领域研究的快速发展,越来越多的近红外量子点被广泛用于生物大分子和细胞标记、组织和活体细胞成像、肿瘤模型定位、临床诊断等多个领域并取得了突破性的进展。Due to the low scattering and good penetration depth of long-wavelength light in living tissue, NIR II (1000-1700 nm) imaging has obvious advantages over traditional NIR I (650-950 nm) imaging in in vivo imaging , making near-infrared quantum dots a hot spot in the field of optical imaging because they can overcome the defects of visible light quantum dots that are susceptible to interference in deep tissue imaging, and can obtain higher-resolution images. Moreover, with the rapid development of research in the field of bioimaging, more and more near-infrared quantum dots have been widely used in biological macromolecules and cell labeling, tissue and living cell imaging, tumor model localization, clinical diagnosis and other fields. breakthrough progress.
硒化银(Ag2Se)作为一种新型的近红外二元含银量子点,因其低毒性、尺寸小且具有优异的近红外光学特性等优势而越来越被广大科研工作者所重视。这种量子点的出现,是对合金量子点在生物领域存在局限性的一种有利补充。一方面,它弥补了含重金属元素(镉或铅)量子点对环境和生物体系毒性较大的问题,可以有效地降低量子点的生物毒性。另一方面,由于其本身为近红外波段量子点,可以很好的与生物组织本身的自发荧光相区分,提高细胞分辨能力,且具有较深的穿透深度,能有更好的进行生物应用。具有手性的近红外二区荧光硒化银量子点制备在技术上具有挑战性,并且在不同的交叉学科领域引起了相当大的关注。目前,所涉及到的近红外量子点多为合金量子点CdSeS、CdHgTe、CdSexTe1等结构已经被很多学者报道,这类合金量子点的弊端在于量子点本身含有重金属Cd,从而使得其在生物领域的应用存在一定局限性。但是具有手性的近红外硒化银量子点结构无镉荧光量子点,以此来扩充近红外量子点在生物标记领域的应用是十分必要的。As a new type of near-infrared binary silver-containing quantum dots, silver selenide (Ag 2 Se) has been paid more and more attention by researchers due to its low toxicity, small size and excellent near-infrared optical properties. . The emergence of such quantum dots is a favorable supplement to the limitations of alloy quantum dots in the biological field. On the one hand, it makes up for the problem that quantum dots containing heavy metal elements (cadmium or lead) are highly toxic to the environment and biological systems, and can effectively reduce the biological toxicity of quantum dots. On the other hand, because it is a quantum dot in the near-infrared band, it can be well distinguished from the autofluorescence of biological tissue itself, improve the cell resolution ability, and has a deep penetration depth, which can be better for biological applications. . The preparation of chiral near-infrared second-region fluorescent silver selenide quantum dots is technically challenging and has attracted considerable attention in different interdisciplinary fields. At present, most of the near-infrared quantum dots involved are alloy quantum dots CdSeS, CdHgTe, CdSexTe1 and other structures, which have been reported by many scholars. The application has certain limitations. However, the chiral near-infrared silver selenide quantum dot structure is cadmium-free fluorescent quantum dots, which is very necessary to expand the application of near-infrared quantum dots in the field of biomarkers.
发明内容SUMMARY OF THE INVENTION
为解决上述技术问题,本发明提供了一种稀土掺杂硒化银量子点及其合成方法。In order to solve the above technical problems, the present invention provides a rare earth doped silver selenide quantum dot and a synthesis method thereof.
一种稀土掺杂硒化银量子点的合成方法,包括以下步骤:A method for synthesizing rare earth doped silver selenide quantum dots, comprising the following steps:
(1)将硒粉加入有机膦溶液中,避光条件下搅拌混合均匀,得到硒-有机膦溶液;(1) adding the selenium powder to the organic phosphine solution, stirring and mixing evenly under the dark condition to obtain a selenium-organophosphine solution;
(2)将稀土金属盐加入有机膦溶液中反应,得到稀土元素前驱体;(2) adding the rare earth metal salt into the organic phosphine solution to react to obtain the rare earth element precursor;
(3)将十八烷烯(ODE)、硫醇和乙酸银混合,在惰性气体中加热至160-180℃反应10-40min,得到澄清的反应溶液;(3) mixing octadecene (ODE), mercaptan and silver acetate, heating to 160-180 DEG C in an inert gas for 10-40min to obtain a clear reaction solution;
(4)将步骤(1)中所述硒-有机膦溶液与手性配体加入步骤(3)中所述反应溶液中并混合均匀,在惰性氛围下加热160-180℃反应1-4h,待反应结束加入步骤(2)中所述稀土元素前驱体,加热160-180℃反应1-2h得到所述稀土元素掺杂硒化银量子点。(4) adding the selenium-organophosphine solution and the chiral ligand described in the step (1) into the reaction solution described in the step (3) and mixing evenly, heating at 160-180° C. for 1-4 hours under an inert atmosphere, After the reaction is completed, the rare earth element precursor in step (2) is added, and the rare earth element doped silver selenide quantum dots are obtained by heating at 160-180° C. for 1-2 hours and reacting for 1-2 hours.
在本发明的一个实施例中,步骤(1)中,所述有机膦为三辛基膦、三正辛基氧化膦和三丁基氧磷中的一种或多种。In an embodiment of the present invention, in step (1), the organic phosphine is one or more of trioctylphosphine, tri-n-octylphosphine oxide and tributylphosphorus oxide.
在本发明的一个实施例中,步骤(2)中,所述稀土金属盐选自氯化钕、氯化镱和氯化铒。In an embodiment of the present invention, in step (2), the rare earth metal salt is selected from neodymium chloride, ytterbium chloride and erbium chloride.
在本发明的一个实施例中,所述氯化钕、氯化镱和氯化铒的摩尔比为1:3-5:4-5。In an embodiment of the present invention, the molar ratio of neodymium chloride, ytterbium chloride and erbium chloride is 1:3-5:4-5.
在本发明的一个实施例中,步骤(3)中,所述十八烷烯(ODE)与硫醇的体积比为15-5:17-3。In an embodiment of the present invention, in step (3), the volume ratio of octadecene (ODE) to thiol is 15-5:17-3.
在本发明的一个实施例中,步骤(3)中,所述乙酸银浓度为0.2mM-1mM。In an embodiment of the present invention, in step (3), the concentration of silver acetate is 0.2mM-1mM.
在本发明的一个实施例中,步骤(3)中,所述硫醇为十二硫醇或/和叔十二硫醇。In an embodiment of the present invention, in step (3), the thiol is dodecanethiol or/and tert-dodecanethiol.
在本发明的一个实施例中,步骤(4)中,所述手性配体为联二萘胺、联二萘酚和萘基乙胺中的一种或多种。In an embodiment of the present invention, in step (4), the chiral ligand is one or more of binaphthylamine, binaphthol and naphthylethylamine.
在本发明的一个实施例中,步骤(4)中,所述手性配体浓度为2mM-10mM。In an embodiment of the present invention, in step (4), the concentration of the chiral ligand is 2mM-10mM.
本发明还提供了所述的合成方法制备得到稀土元素掺杂硒化银量子点。The invention also provides the rare earth element-doped silver selenide quantum dots prepared by the synthesis method.
本发明的上述技术方案相比现有技术具有以下优点:The above-mentioned technical scheme of the present invention has the following advantages compared with the prior art:
本发明所述的通过高温油相合成法实现对Ag2Se量子点进行制备,通过改变Ag:Se比获得不同尺寸的Ag2Se量子点,并对所制备的量子点从光学特性及结构特性方面进行对比分析,以此寻找制备该种量子点的最佳Ag:Se比。此后,通过掺杂稀土元素对荧光强度进行大幅度的增强并红移了荧光发射峰的位置,利用联二萘胺、联二萘酚、萘基乙胺等对量子点进行手性修饰使其具备手性,并对修饰后的量子点进行物化特性表征分析,以此验证将Ag2Se应用于生物标记领域的可行性,为这种量子点在生物领域的应用提供可靠依据。According to the present invention, Ag 2 Se quantum dots are prepared by a high temperature oil phase synthesis method, Ag 2 Se quantum dots of different sizes are obtained by changing the Ag:Se ratio, and the optical properties and structural properties of the prepared quantum dots are analyzed from the perspective of optical properties and structural properties. In order to find the optimal Ag:Se ratio for preparing the quantum dots, a comparative analysis was carried out. After that, the fluorescence intensity was greatly enhanced by doping rare earth elements and the position of the fluorescence emission peak was red-shifted. It has chirality, and the physicochemical properties of the modified quantum dots are characterized and analyzed to verify the feasibility of applying Ag 2 Se to the field of biomarkers, and to provide a reliable basis for the application of this quantum dot in the biological field.
附图说明Description of drawings
为了使本发明的内容更容易被清楚的理解,下面根据本发明的具体实施例并结合附图,对本发明作进一步详细的说明,其中In order to make the content of the present invention easier to understand clearly, the present invention will be described in further detail below according to specific embodiments of the present invention and in conjunction with the accompanying drawings, wherein
图1是本发明手性近红外二区荧光硒化银量子点的制备方法流程图。Fig. 1 is the flow chart of the preparation method of chiral near-infrared second region fluorescent silver selenide quantum dots of the present invention.
图2是本发明手性近红外二区荧光硒化银量子点透射电镜照片。Figure 2 is a transmission electron microscope photograph of the chiral near-infrared second region fluorescent silver selenide quantum dots of the present invention.
图3是本发明手性近红外二区荧光硒化银量子点的圆二色谱(CD)图。3 is a circular dichroism (CD) diagram of the chiral near-infrared second region fluorescent silver selenide quantum dots of the present invention.
图4是本发明手性近红外二区荧光硒化银量子点的紫外图。FIG. 4 is an ultraviolet image of the chiral near-infrared second-region fluorescent silver selenide quantum dots of the present invention.
图5是本发明手性近红外二区荧光硒化银量子点的荧光增强效果图。5 is a graph showing the fluorescence enhancement effect of the chiral near-infrared second region fluorescent silver selenide quantum dots of the present invention.
具体实施方式Detailed ways
下面结合附图和具体实施例对本发明作进一步说明,以使本领域的技术人员可以更好地理解本发明并能予以实施,但所举实施例不作为对本发明的限定。The present invention will be further described below with reference to the accompanying drawings and specific embodiments, so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
实施例1Example 1
1,将191mg硒粉加入到2mL三丁基膦溶液中,避光搅拌3h,得到硒-三丁基膦溶液,另外将0.5mmol氯化钕、氯化镱、氯化铒加入各加入5mL三丁基膦溶液中得到钕-三丁基膦溶液、镱-三丁基膦溶液、铒-三丁基膦溶液。1. Add 191 mg of selenium powder to 2 mL of tributylphosphine solution, and stir in the dark for 3 hours to obtain a selenium-tributylphosphine solution. In addition, 0.5 mmol of neodymium chloride, ytterbium chloride and erbium chloride were added to each of 5 mL of tributylphosphine chloride. A neodymium-tributylphosphine solution, a ytterbium-tributylphosphine solution, and an erbium-tributylphosphine solution were obtained from the butylphosphine solution.
2,将16mL十八烯,4mL十二硫醇和60mg乙酸银加入三颈烧瓶中,在氮气保护下升温至160℃,在所述预设温度下继续反应10min,得到澄清的反应溶液。2. Add 16 mL of octadecene, 4 mL of dodecanethiol and 60 mg of silver acetate into a three-necked flask, heat up to 160° C. under nitrogen protection, and continue the reaction at the preset temperature for 10 min to obtain a clear reaction solution.
3,在反应液中注入200μL硒-三丁基膦溶液与联2萘酚,在氮气保护下升温至160℃,在所述预设温度下继续反应30min。3. Inject 200 μL of selenium-tributylphosphine solution and binaphthol into the reaction solution, raise the temperature to 160° C. under nitrogen protection, and continue the reaction at the preset temperature for 30 min.
4,在反应液中注入20μL钕-三丁基膦溶液、80μL镱-三丁基膦溶液、120μL铒-三丁基膦溶液,在氮气保护在所述预设温度下继续反应2h。4. Inject 20 μL of neodymium-tributylphosphine solution, 80 μL of ytterbium-tributylphosphine solution, and 120 μL of erbium-tributylphosphine solution into the reaction solution, and continue the reaction for 2 hours at the preset temperature under nitrogen protection.
5,反应结束后,冷却至室温,加入三氯甲烷防止凝固。5. After the reaction, cool to room temperature and add chloroform to prevent solidification.
6,利用丙酮进行离心洗涤处理。6. Perform centrifugal washing treatment with acetone.
添加三氯甲烷至所述反应液中,得到分散在三氯甲烷中的硒化银荧光量子点溶液。Trichloromethane is added to the reaction solution to obtain a solution of silver selenide fluorescent quantum dots dispersed in chloroform.
实施例2Example 2
1,将179mg硒粉加入到3mL三丁基膦溶液中,避光搅拌4h,得到硒-三丁基膦溶液。1. Add 179 mg of selenium powder to 3 mL of tributylphosphine solution, and stir in the dark for 4 h to obtain a selenium-tributylphosphine solution.
2,将17mL十八烯,3mL十二硫醇和65mg乙酸银加入三颈烧瓶中,在氮气保护下升温至170℃,在所述预设温度下继续反应8min,得到澄清的反应溶液。2. Add 17 mL of octadecene, 3 mL of dodecanethiol and 65 mg of silver acetate into a three-necked flask, heat up to 170° C. under nitrogen protection, and continue to react for 8 min at the preset temperature to obtain a clear reaction solution.
3,在反应液中注入200μL硒-三丁基膦溶液与联2萘酚,在氮气保护下升温至160℃,在所述预设温度下继续反应20min。3. Inject 200 μL of selenium-tributylphosphine solution and binaphthol into the reaction solution, raise the temperature to 160° C. under nitrogen protection, and continue the reaction at the preset temperature for 20 min.
4,在反应液中注入10μL钕-三丁基膦溶液、100μL镱-三丁基膦溶液、100μL铒-三丁基膦溶液,在氮气保护在所述预设温度下继续反应2h。4. Inject 10 μL of neodymium-tributylphosphine solution, 100 μL of ytterbium-tributylphosphine solution, and 100 μL of erbium-tributylphosphine solution into the reaction solution, and continue the reaction for 2 hours at the preset temperature under nitrogen protection.
5,反应结束后,冷却至室温,加入三氯甲烷防止凝固。5. After the reaction, cool to room temperature and add chloroform to prevent solidification.
6,利用丙酮进行离心洗涤处理。6. Perform centrifugal washing treatment with acetone.
7,添加三氯甲烷至所述反应液中,得到分散在三氯甲烷中的硒化银荧光量子点溶液。7. Add chloroform to the reaction solution to obtain a solution of silver selenide fluorescent quantum dots dispersed in chloroform.
实施例3Example 3
1,将188mg硒粉加入到2mL三丁基膦溶液中,避光搅拌4h,得到硒-三丁基膦溶液。1. Add 188 mg of selenium powder to 2 mL of tributylphosphine solution, and stir in the dark for 4 h to obtain a selenium-tributylphosphine solution.
2,将16mL十八烯,3mL十二硫醇和67mg乙酸银加入三颈烧瓶中,在氮气保护下升温至165℃,在所述预设温度下继续反应8min,得到澄清的反应溶液。2. Add 16 mL of octadecene, 3 mL of dodecanethiol and 67 mg of silver acetate into a three-necked flask, heat up to 165° C. under nitrogen protection, and continue to react for 8 min at the preset temperature to obtain a clear reaction solution.
3,在反应液中注入200μL硒-三丁基膦溶液与联2萘酚,在氮气保护下升温至160℃,在所述预设温度下继续反应20min。3. Inject 200 μL of selenium-tributylphosphine solution and binaphthol into the reaction solution, raise the temperature to 160° C. under nitrogen protection, and continue the reaction at the preset temperature for 20 min.
4,在反应液中注入20μL钕-三丁基膦溶液、90μL镱-三丁基膦溶液、90μL铒-三丁基膦溶液,在氮气保护在所述预设温度下继续反应2h。4. Inject 20 μL of neodymium-tributylphosphine solution, 90 μL of ytterbium-tributylphosphine solution, and 90 μL of erbium-tributylphosphine solution into the reaction solution, and continue the reaction for 2 hours at the preset temperature under nitrogen protection.
5,反应结束后,冷却至室温,加入三氯甲烷防止凝固。5. After the reaction, cool to room temperature and add chloroform to prevent solidification.
6,利用丙酮进行离心洗涤处理。6. Perform centrifugal washing treatment with acetone.
7,添加三氯甲烷至所述反应液中,得到分散在三氯甲烷中的硒化银荧光量子点溶液。7. Add chloroform to the reaction solution to obtain a solution of silver selenide fluorescent quantum dots dispersed in chloroform.
性能测试Performance Testing
经过掺杂的材料通过荧光测试,在相同功率的808nm的激发下,可以达到更强的荧光强度,强度可以增强120倍,并且发射峰的位置从1100nm红移至1500nm,能够具备更强的红外二区荧光成像效果。(实验结果见图5)。The doped material has passed the fluorescence test. Under the excitation of 808nm with the same power, it can achieve a stronger fluorescence intensity, the intensity can be enhanced by 120 times, and the position of the emission peak is red-shifted from 1100nm to 1500nm, which can have a stronger infrared Two-zone fluorescence imaging effect. (The experimental results are shown in Figure 5).
综上所述,通过高温油相合成法实现对Ag2Se量子点进行制备,通过改变Ag:Se比获得不同尺寸的Ag2Se量子点,并对所制备的量子点从光学特性及结构特性方面进行对比分析,以此寻找制备该种量子点的最佳Ag:Se比。此后,掺杂最优比例的Nd3+、Yb3+、Er3+大幅增强了荧光的发光效率,再利用联二萘胺、联二萘酚、萘基乙胺等对量子点进行手性修饰使其具备手性,并对修饰后的量子点进行物化特性表征分析,以此验证将Ag2Se应用于生物标记领域的可行性,为这种量子点在生物领域的应用提供可靠依据。In summary, Ag 2 Se quantum dots were prepared by high temperature oil phase synthesis method, Ag 2 Se quantum dots of different sizes were obtained by changing the Ag:Se ratio, and the optical properties and structural properties of the prepared quantum dots were analyzed. In order to find the optimal Ag:Se ratio for preparing the quantum dots, a comparative analysis was carried out. After that, doping the optimal ratio of Nd 3+ , Yb 3+ , Er 3+ greatly enhanced the luminous efficiency of fluorescence, and then used binaphthylamine, binaphthol, naphthylethylamine, etc. to chiral the quantum dots The modification makes it chirality, and the physicochemical properties of the modified quantum dots are characterized and analyzed to verify the feasibility of applying Ag 2 Se to the field of biomarkers, and to provide a reliable basis for the application of this quantum dot in the biological field.
显然,上述实施例仅仅是为清楚地说明所作的举例,并非对实施方式的限定。对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式变化或变动。这里无需也无法对所有的实施方式予以穷举。而由此所引申出的显而易见的变化或变动仍处于本发明创造的保护范围之中。Obviously, the above-mentioned embodiments are only examples for clear description, and are not intended to limit the implementation manner. For those of ordinary skill in the art, other different forms of changes or modifications can also be made on the basis of the above description. There is no need and cannot be exhaustive of all implementations here. However, the obvious changes or changes derived from this are still within the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111188492.8A CN113881435B (en) | 2021-10-12 | 2021-10-12 | Rare earth doped silver selenide quantum dot and synthesis method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111188492.8A CN113881435B (en) | 2021-10-12 | 2021-10-12 | Rare earth doped silver selenide quantum dot and synthesis method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113881435A CN113881435A (en) | 2022-01-04 |
CN113881435B true CN113881435B (en) | 2022-08-30 |
Family
ID=79006366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111188492.8A Active CN113881435B (en) | 2021-10-12 | 2021-10-12 | Rare earth doped silver selenide quantum dot and synthesis method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113881435B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104449737A (en) * | 2013-09-25 | 2015-03-25 | 海洋王照明科技股份有限公司 | Holmium-ytterbium co-doped silver selenium salt up-conversion luminescent material as well as preparation method and application thereof |
CN103840034B (en) * | 2014-01-17 | 2016-02-17 | 南昌航空大学 | The preparation of rare earth selenide quantum dots solar cell and application thereof |
CN104277822A (en) * | 2014-10-07 | 2015-01-14 | 复旦大学 | 800 nm near-infrared excitation, 1525 nm short-wave infrared emission fluorescent nanomaterial and its synthesis method |
CN105129748B (en) * | 2015-08-24 | 2018-03-06 | 南京邮电大学 | A kind of method for preparing Transition-metal dichalcogenide quantum dot |
CN106867532B (en) * | 2017-03-16 | 2019-11-26 | 武汉理工大学 | Lanthanide rare ytterbium adulterates silver sulfide quantum dot and its preparation method and application |
CN113237934B (en) * | 2021-05-24 | 2024-04-09 | 常州大学 | A chiral silver sulfide quantum dot/few-layer carbon nitride composite for electrochemiluminescence chiral recognition and preparation method thereof |
-
2021
- 2021-10-12 CN CN202111188492.8A patent/CN113881435B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113881435A (en) | 2022-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Marin et al. | Doping lanthanide ions in colloidal semiconductor nanocrystals for brighter photoluminescence | |
CN110117024B (en) | Zero-dimensional lead-free cesium copper iodoperovskite blue light nanocrystal and preparation method thereof | |
CN104804741B (en) | Single-emission up-conversion nano fluorescent probe and synthetic method thereof | |
CN103450875B (en) | 800-nanometer continuous laser excited rare earth upconversion nanoparticles (UCNPs), and preparation method and application thereof | |
Wang et al. | Near-infrared excitation of CdTe quantum dots based on fluorescence resonance energy transfer and their use as fluorescent sensors | |
CN106379932A (en) | A method of synthesizing a perovskite CsPbX3 quantum dot at room temperature | |
Kar et al. | Impact of Zn-doping on the composition, stability, luminescence properties of silica coated all-inorganic cesium lead bromide nanocrystals and their biocompatibility | |
CN112080278A (en) | An up/down conversion dual-mode luminescent nanocrystal and its preparation method and application | |
CN110878207A (en) | A kind of up-conversion nano-optical switch material and preparation method thereof | |
CN111303879B (en) | A high-efficiency single-band upconversion red light nanocrystalline material | |
Marin et al. | Harnessing the synergy between upconverting nanoparticles and lanthanide complexes in a multiwavelength-responsive hybrid system | |
CN104560033A (en) | Preparation method of novel high-efficient luminescence Mn-doped quantum dots | |
CN106867532B (en) | Lanthanide rare ytterbium adulterates silver sulfide quantum dot and its preparation method and application | |
CN112940726A (en) | Blue-violet and near-infrared two-region dual-mode luminescent nanocrystal and preparation method thereof | |
CN107418554A (en) | A kind of gold nanorods and upper conversion nano crystalline substance composite nano materials and preparation method thereof | |
Peng et al. | Near-infrared emitting gold–silver nanoclusters with large Stokes shifts for two-photon in vivo imaging | |
CN111253931A (en) | Up-conversion core-shell-based covalent organic framework material, and preparation method and application thereof | |
Yang et al. | Nonstoichiometric nanocubes with a controllable morphology and persistent luminescence for autofluorescence-free biosensing | |
CN114032091A (en) | Ternary metal halide with ultra-high fluorescence efficiency and preparation method thereof | |
CN113881435B (en) | Rare earth doped silver selenide quantum dot and synthesis method thereof | |
CN105018069B (en) | A kind of nuclear shell structure quantum point and its aqueous phase preparation method with long fluorescence lifetime | |
CN108441208A (en) | Preparation method of single-particle multicolor luminous nano material | |
Ding et al. | Nd3+/Yb3+ cascade-sensitized single-band red upconversion emission in active-core/active-shell nanocrystals | |
CN105505374B (en) | A kind of up-conversion luminescence composite material based on dye sensitization and preparation method thereof | |
CN106244140B (en) | A near-infrared long-lasting nanomaterial activated by divalent nickel ions and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |